Evidence map›Paper›PMID 31382586›Full record

ReviewInternational journal of molecular sciences2019

Peroxisomes and Innate Immunity: Antiviral Response and Beyond.

Ana Rita Ferreira, Mariana Marques, Daniela Ribeiro

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. The peroxisome: an update on mysteries 3.0.Histochemistry and cell biology · 2024
    Review
  10. Super-Resolution Imaging of Peroxisomal Proteins Using STED Nanoscopy.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  11. Tools to Investigate the Peroxisome-Dependent Antiviral Response.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  12. Review
  13. Review
  14. Review
  15. The type I interferonopathies: 10 years on.Nature reviews. Immunology · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ana Rita FerreiraInstitute of Biomedicine (iBiMED) & Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal.
Mariana MarquesInstitute of Biomedicine (iBiMED) & Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0003-1284-334X
Daniela RibeiroInstitute of Biomedicine (iBiMED) & Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal. daniela.ribeiro@ua.pt.ORCID 0000-0003-3397-0460
University of Aveiro · PT

Funding

Fundação para a Ciência e a Tecnologia PTDC/BIA-CEL/31378/2017
6 · The paper itself

Abstract

Peroxisomes are ubiquitous organelles with well-defined functions in lipid and reactive oxygen species metabolism, having a significant impact on a large number of important diseases. Growing evidence points to them, in concert with mitochondria, as important players within the antiviral response. In this review we summarize and discuss the recent findings concerning the relevance of peroxisomes within innate immunity. We not only emphasize their importance as platforms for cellular antiviral signaling but also review the current information concerning their role in the control of bacterial infections. We furthermore review the recent data that pinpoints peroxisomes as regulators of inflammatory processes.

Indexed as

Immunity, InnateAdaptor Proteins, Signal TransducingAntiviral AgentsBacterial InfectionsHumansPeroxisomesReactive Oxygen SpeciesAdaptor Proteins, Signal TransducingAntiviral AgentsReactive Oxygen Speciesbacteriainflammationinnate immunitymicrobesmitochondrial antiviral signaling protein (MAVS)peroxisomessignalingviruses

Identifiers

PMID31382586
PMCPMC6695817
OpenAlexW2964822513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.